ConductScience.org, home

Trial · NCT03792191

Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery

NCT03792191, Not applicable, Completed, Mansoura University; results first posted 2021-05-24

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery. Trials, record NCT03792191. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03792191

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery
NCT number
NCT03792191
Status
Completed
Phases
Not applicable
Enrollment
280 participants, actual
Lead sponsor
Mansoura University
Conditions
Anesthesia, Spinal, Cesarean Section, Spinal Ultrasound
Interventions
Lumbar Spinal Ultrasonography, Sham Ultrasound Procedure, Conventional Landmark Palpation, Spinal Anesthesia, Intrathecal Bupivacaine, Intrathecal Fentanyl
First posted
2019-01-03
Last updated
2021-05-24
Results first posted
2021-05-24

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Needle Passes Required to Obtain Free Cerebrospinal Fluid FlowAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesNeedle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.
SecondaryNumber of Skin Punctures Required to Obtain Free Cerebrospinal Fluid FlowAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesSkin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.
SecondaryRate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle PassAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesNeedle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.
SecondaryRate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin PunctureAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesSkin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.
SecondaryDuration of the Spinal ProcedureAssessed from enrollment in the study until completion of cesarean deliveryThe duration from starting the first skin puncture by the spinal needle to obtaining free CSF flow
SecondaryPatient SatisfactionAssessed at 1 minute after intrathecal injectionPatient satisfaction from the procedure assessed immediately after intrathecal injection using a 5-point scale (1 = very unsatisfied; 2 = unsatisfied; 3 = fair; 4 = satisfied; and 5 = very satisfied).
SecondaryNumber of Participants With Vascular PunctureAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesNumber of participants with unintentional vascular puncture by the needle during performing the spinal procedure
SecondaryNumber of Participants With ParesthesiaAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesNumber of participants with paresthesia reported by the subjects during performing the spinal procedure
SecondaryNumber of Participants With Failure to Obtain Free Cerebrospinal Fluid FlowAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesNumber of participants with failure to obtain free cerebrospinal fluid flow after adequate needle passes at 6 separate skin punctures.
SecondaryNumber of Participants With Failed Spinal BlockAssessed up to 20 minutes after intrathecal injectionNumber of participants with failed spinal block defined as an upper sensory level below T6 assessed by pinprick.

Outcomes10

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Needle Passes Required to Obtain Free Cerebrospinal Fluid FlowAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesneedle passesMEDIAN
SECONDARYNumber of Skin Punctures Required to Obtain Free Cerebrospinal Fluid FlowAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesskin puncturesMEDIAN
SECONDARYRate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle PassAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYRate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin PunctureAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYDuration of the Spinal ProcedureAssessed from enrollment in the study until completion of cesarean deliverysecondsMEDIAN
SECONDARYPatient SatisfactionAssessed at 1 minute after intrathecal injectionunits on a scaleMEDIAN
SECONDARYNumber of Participants With Vascular PunctureAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With ParesthesiaAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Failure to Obtain Free Cerebrospinal Fluid FlowAssessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutesParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Failed Spinal BlockAssessed up to 20 minutes after intrathecal injectionParticipantsCOUNT_OF_PARTICIPANTS

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Needle Passes Required to Obtain Free Cerebrospinal Fluid FlowUltrasonography3Full Range 1 to 34needle passes
Number of Needle Passes Required to Obtain Free Cerebrospinal Fluid FlowPalpation3Full Range 1 to 23needle passes
Number of Skin Punctures Required to Obtain Free Cerebrospinal Fluid FlowUltrasonography1Full Range 1 to 6skin punctures
Number of Skin Punctures Required to Obtain Free Cerebrospinal Fluid FlowPalpation1Full Range 1 to 4skin punctures
Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle PassUltrasonography40Participants
Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle PassPalpation45Participants
Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin PunctureUltrasonography108Participants
Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin PuncturePalpation111Participants
Duration of the Spinal ProcedureUltrasonography76Full Range 26 to 734seconds
Duration of the Spinal ProcedurePalpation59Full Range 19 to 700seconds

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDUltrasonography140
Overall StudySTARTEDPalpation140
Overall StudyCOMPLETEDUltrasonography140
Overall StudyCOMPLETEDPalpation140
Overall StudyNOT COMPLETEDUltrasonography0
Overall StudyNOT COMPLETEDPalpation0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityUltrasonography0140
Total, all-cause mortalityPalpation0140
Total, other adverse eventsUltrasonography0140
Total, other adverse eventsPalpation0140
Total, serious adverse eventsUltrasonography0140
Total, serious adverse eventsPalpation0140

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
37188389DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons8

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Ultrasonography vs Palpation: Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle PassTrial comparisons
Ultrasonography vs Palpation: Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin PunctureTrial comparisons
Ultrasonography vs Palpation: Number of Participants With Vascular PunctureTrial comparisons
Ultrasonography vs Palpation: Number of Participants With Failure to Obtain Free Cerebrospinal Fluid FlowTrial comparisons
Ultrasonography vs Palpation: Number of Participants With ParesthesiaTrial comparisons
Ultrasonography vs Palpation: Number of Participants With Failed Spinal BlockTrial comparisons
Ultrasonography vs Palpation: deaths from any causeTrial comparisons
Ultrasonography vs Palpation: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03792191

GET https://conductscience.org/api/trials/v1/NCT03792191/registered